Northwestern Medicine scientists have developed an AI tool that not only matches doctors in accurately outlining lung tumors on CT scans but can also identify areas that some doctors may miss, according to a new study.
Northwestern Medicine scientists have uncovered key details about a group of rare but serious blood disorders, according to a study published in the Journal of Clinical Investigation.
Northwestern Medicine scientists have developed a promising approach to killing treatment-resistant cancer cells by exploiting their hidden metabolic vulnerabilities, according to a study published in the Proceedings of the National Academy of Sciences (PNAS).
Genetic makeup and structure can shift dramatically across different areas of a single glioblastoma tumor, reveals a Northwestern Medicine study published in Science Advances.
A newly developed scoring system could enhance risk prediction and guide treatment decisions for colorectal cancer, according to a study published in the Journal of Clinical Oncology.
Northwestern Medicine investigators have discovered that a novel long noncoding RNA, which are usually 200 nucleotides longer than typical RNAs, could serve as a prognostic biomarker and therapeutic target for prostate cancer, according to a recent study published in Science Advances.
A pair of recent studies from the laboratory of Bin Zhang, MD, PhD, the Johanna Dobe Professor of Cancer Immunology, have uncovered new details about critical immunological processes that may help improve cancer treatments, according to the findings.
Northwestern Medicine investigators have discovered new intracellular mechanisms that help specialized immune cells adapt and respond to disease and acute inflammation, findings that may inform the development of targeted therapies for cancer and tissue injury, according to a recent study published in the Journal of Clinical Investigation.
Northwestern Medicine scientists have identified a key driver of chemotherapy resistance in advanced ovarian cancer, according to a study published in the Journal of Clinical Investigation.
Northwestern Medicine scientists have uncovered how a testis-specific protein contributes to tumor growth and progression when it is mis-expressed in lung cancer, according to a study published in Science Advances.